Abstracts (HTML) List of Authors

Haas, D

Removal of citrate from PAS-III additive solution improves functional and biochemical characteristics of buffy-coat platelet concentrates stored for seven days, with or without Intercept pathogen reduction

Häberle, H

Platelet activation and apoptosis in COVID-19 infection: data from an observational study

Hagedorn, N

Noonon syndrome as unlikely cause of increased bruising in a case of suspected battered child syndrome

Haidl, H

The contribution of bile acid transport and endoplasmatic reticulum stress to tissue factor activation in hepatocytes

Haindl, S

Robust and selective chromogenic measurement of factor VIII activity with an antibody-based factor VIII chromogenic assay

Halfon, P

Evolution of platelet phenotype during SARS-CoV-2 infection

Halimeh, S

Causes of Acquired von Willebrands Disease Type II in Pediatric Patients. Cases and literature review.

Hammer, S

Platelet activation and apoptosis in COVID-19 infection: data from an observational study

Hammerschmidt, S

Antibodies protect platelet damage by pneumolysin

Handtke, S

In-vivo model to assess platelet age in humans: during increased platelet turnover large and small platelets are produced simultaneously
Antibodies protect platelet damage by pneumolysin

Hansmann, G

Acquired von Willebrand Syndrom (avWS) Typ 2 in children with severe pulmonary arterial hypertension (PAH)

Hardy, C

Characterization of rFIX fusion proteins enabling subcutaneous administration
In vitro characterization of K5A and K5R variants of Factor IX

Hardy, M

Prothrombotic Disturbances of Hemostasis of Patients with Severe COVID-19: a Prospective Longitudinal Observational Study

Harenberg, J

Implementation of Direct Oral Anticoagulant (DOAC) Perioperative Interruption and Interval evaluation of the DOASENSE Dipstick performance
Impact of DOAC Dipstick test and relation to plasma and urine concentrations to exclude the presence of clinically relevant concentrations of DOACs in real-life patient setting – study protocol and case reports
Interaction of direct oral anticoagulants and other anticoagulants on DOAC Dipstick test
Analysis of adherence to therapy comparing DOAC Dipstick test with plasma concentration of rivaroxaban and apixaban in outpatients with venous thromboembolic disease
Clinical usefulness of the novel DOAC Dipstick near patient test strip in emergency settings using semi-automatic DOASENSE Reader
Abnormal urine is detected by a specific pad of DOAC Dipstick near patient test strip
A bedside urine based test strip on identifying anticoagulation with direct oral anticoagulants at a high-volume emergency department – a diagnostic test accuracy study

Hart, C

Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication
Case report: Use of recombinant von Willebrand factor in a patient with acquired von Willebrand syndrome due to specific IgM-antibodies directed against vWF

Haslacher, H

Increased soluble thrombomodulin influences fibrin clot formation in patients with mild to moderate bleeding tendency

Hechler, B

Removal of citrate from PAS-III additive solution improves functional and biochemical characteristics of buffy-coat platelet concentrates stored for seven days, with or without Intercept pathogen reduction
Severity of Transfusion-Related Acute Lung Injury in mice expressing human FcgRIIA is determined by platelet-released serotonin
Cooperation of platelet beta1 and beta3 integrins in the arrest of inflammatory bleeding in mice

Hecking, M

Anticoagulation for stroke prevention in patients with atrial fibrillation on hemodialysis is associated with net-clinical harm

Heemskerk, J

Platelet-derived chemokines regulating neutrophil activation stages in arterial thrombus formation

Hegemann, I

Long-term Efficacy and Safety of Fitusiran in Participants with Hemophilia A and B: An Interim Analysis of the Phase 1/2 Open-Label Extension Study
Evaluation of thrombin generation in patients with sickle cell disease in stable disease and sickle cell crises

Heim, V

Human platelets labeled at two discrete biotin densities are functional in vitro and are detected in vivo in the mouse circulation. A promising approach to monitor in vivo platelet survival in clinical research

Heimerl, S

Case report: Use of recombinant von Willebrand factor in a patient with acquired von Willebrand syndrome due to specific IgM-antibodies directed against vWF

Heinken, A

Anticoagulation practice of cancer-associated thrombosis in the outpatient sector of Germany

Henriet, C

Safety and efficacy of a high-purity plasma derived von Willebrand Factor in patients with von Willebrand disease (VWD) undergoing prophylaxis for joint bleeding: results from a post-marketing study
Safety and efficacy of a high-purity plasma-derived von Willebrand Factor in patients with von Willebrand disease (VWD) undergoing prophylaxis for gastrointestinal bleeding: results from a post-marketing study

Herbener, P

The Innovative Factor VIII Molecules HAT and HAT RI Overcome Impairments of Hemophilia A Therapy

Herkner, H

Clinical usefulness of the novel DOAC Dipstick near patient test strip in emergency settings using semi-automatic DOASENSE Reader
A bedside urine based test strip on identifying anticoagulation with direct oral anticoagulants at a high-volume emergency department – a diagnostic test accuracy study

Hermans, C

Treatment with Eptacog Beta (Factor VIIa, Recombinant) Results in Early Bleed Resolution for Persons with Hemophilia A or B with Inhibitors: Results of the randomized cross-over PERSEPT 1 phase 3 study

Herr, W

Case report: Use of recombinant von Willebrand factor in a patient with acquired von Willebrand syndrome due to specific IgM-antibodies directed against vWF

Hertfelder, HJ

Thrombophilic Phaenotype in a Family with High Frequency of Homozygous Antithrombin Deficiency Typ IIb Budapest 3 and Mild Factor VII Deficiency due to Homozygous Polymorphisms in the Factor 7 Gene and Antithrombotic Treatment

Hetjens, S

Interaction of direct oral anticoagulants and other anticoagulants on DOAC Dipstick test

Hezard, N

Evolution of platelet phenotype during SARS-CoV-2 infection

Hlusi, A

Detection thrombogenicity antiphospolipid antibodies with APC modified TGT
Non-criteria antiphospholipid antibodies anti-PT/PS, anti-Anexin V: benefit in diagnostics of antiphospholipid syndrome?

Hofer, S

Increased soluble thrombomodulin influences fibrin clot formation in patients with mild to moderate bleeding tendency

Hoffmann, T

Acquired von Willebrand syndrome associated with monoclonal gammopathy of undetermined significance – successful treatment with lenalidomide and dexamethasone

Holle, J

Assessment of the anticoagulant effect of direct oral anticoagulants (DOACs) in patients needing immediate management during emergency procedures

Holstein, K

Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication
Pain status in patients with hemophilia: evaluation of routine pain assessment in an unselected cohort of patients with hemophilia A and B

Holzhauer, S

Real-world experience on the use of rIX-FP in patients with haemophilia B: Interim results from a prospective, non-interventional, post-market surveillance study in Germany

Hoppenstaedt, D

Sulodexide as a Parenteral Anticoagulant. A Substitute for Unfractionated Heparin.

Hoppensteadt, D

A Comparison of Functional Methods with Absolute Quantification of Heparin Levels in Clinical Samples by Heparin Red Assay
Hepatic Disorders Contribute to Platelet Dysfunction
Whole blood anticoagulant effects of Sulodexide as measured by activated clotting time and their neutralization by Protamine sulfate
Sheep Mucosal Heparin as a Substitute for Porcine Mucosal Heparin. A Viable Option to Address the Potential Shortage Crisis.
Quantification of Bovine and Porcine Heparin Red Assay Utilizing the Heparin Red Assay. Applications in the Study of Pharmacokinetics and Pharmacodynamics.

Höpting, M

Case report: Use of recombinant von Willebrand factor in a patient with acquired von Willebrand syndrome due to specific IgM-antibodies directed against vWF

Ho-Tin-Noé, B

Cooperation of platelet beta1 and beta3 integrins in the arrest of inflammatory bleeding in mice

Hoylaerts, MF

Platelet Distribution Width as a marker of platelet reactivity and platelet activation status in men and women of the Moli-family cohort

Hurler, L

Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients